LGT Capital Partners LTD. Sells 4,874 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

LGT Capital Partners LTD. decreased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 1.7% during the 3rd quarter, Holdings Channel reports. The fund owned 286,428 shares of the healthcare conglomerate’s stock after selling 4,874 shares during the quarter. UnitedHealth Group comprises about 3.4% of LGT Capital Partners LTD.’s holdings, making the stock its 8th biggest position. LGT Capital Partners LTD.’s holdings in UnitedHealth Group were worth $111,919,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Anfield Capital Management LLC acquired a new stake in shares of UnitedHealth Group in the 2nd quarter valued at approximately $26,000. RPg Family Wealth Advisory LLC purchased a new stake in shares of UnitedHealth Group during the 2nd quarter worth $26,000. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. acquired a new position in shares of UnitedHealth Group during the 2nd quarter worth $28,000. Activest Wealth Management acquired a new stake in shares of UnitedHealth Group in the second quarter valued at about $29,000. Finally, Ten Capital Wealth Advisors LLC increased its holdings in UnitedHealth Group by 111.6% in the second quarter. Ten Capital Wealth Advisors LLC now owns 91 shares of the healthcare conglomerate’s stock valued at $36,000 after buying an additional 48 shares in the last quarter. 86.20% of the stock is owned by hedge funds and other institutional investors.

A number of analysts have commented on UNH shares. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $477.00 target price on the stock in a research report on Wednesday, October 27th. Oppenheimer increased their price objective on UnitedHealth Group from $465.00 to $475.00 and gave the company an “outperform” rating in a research note on Friday, October 15th. SVB Leerink assumed coverage on UnitedHealth Group in a report on Monday, September 27th. They issued an “outperform” rating and a $480.00 price target for the company. Deutsche Bank Aktiengesellschaft upped their price objective on shares of UnitedHealth Group from $421.00 to $477.00 and gave the company a “buy” rating in a research note on Tuesday, November 16th. Finally, Royal Bank of Canada lifted their target price on UnitedHealth Group from $473.00 to $476.00 and gave the company an “outperform” rating in a report on Friday, October 15th. One research analyst has rated the stock with a hold rating, twenty-one have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus price target of $477.35.

In other UnitedHealth Group news, Director Richard T. Burke sold 2,500 shares of UnitedHealth Group stock in a transaction on Friday, September 17th. The stock was sold at an average price of $419.00, for a total value of $1,047,500.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Stephen J. Hemsley sold 75,000 shares of the stock in a transaction that occurred on Monday, October 25th. The shares were sold at an average price of $448.72, for a total transaction of $33,654,000.00. The disclosure for this sale can be found here. Over the last three months, insiders have sold 80,000 shares of company stock valued at $35,743,375. Company insiders own 0.55% of the company’s stock.

Shares of NYSE UNH opened at $441.99 on Monday. UnitedHealth Group Incorporated has a one year low of $320.35 and a one year high of $466.00. The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 0.59. The business has a fifty day simple moving average of $428.66 and a 200 day simple moving average of $417.41. The firm has a market capitalization of $416.29 billion, a price-to-earnings ratio of 27.30, a PEG ratio of 1.75 and a beta of 0.85.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, October 14th. The healthcare conglomerate reported $4.52 earnings per share for the quarter, beating the Zacks’ consensus estimate of $4.41 by $0.11. UnitedHealth Group had a net margin of 5.52% and a return on equity of 23.08%. The business had revenue of $72.34 billion for the quarter, compared to analysts’ expectations of $71.24 billion. During the same quarter in the previous year, the firm posted $3.51 earnings per share. The firm’s revenue for the quarter was up 11.1% on a year-over-year basis. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 18.84 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 14th. Shareholders of record on Monday, December 6th will be given a $1.45 dividend. This represents a $5.80 dividend on an annualized basis and a yield of 1.31%. The ex-dividend date of this dividend is Friday, December 3rd. UnitedHealth Group’s dividend payout ratio (DPR) is 35.98%.

UnitedHealth Group Company Profile

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.

Further Reading: Correction

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.